Clostridium difficile and inflammatory bowel disease.
暂无分享,去创建一个
[1] M. Abreu,et al. Clinical Outcomes of Patients with Ulcerative Colitis and Co-existing Clostridium difficile Infection , 2010, Digestive Diseases and Sciences.
[2] A. Staiano,et al. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. , 2009, The Journal of pediatrics.
[3] Dawn B. Beaulieu,et al. S1145 Long-Term Impact of Clostridium difficile On Inflammatory Bowel Disease , 2009 .
[4] D. Leffler,et al. Treatment of Clostridium difficile-associated disease. , 2009, Gastroenterology.
[5] R. Chinn,et al. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. , 2009, American journal of infection control.
[6] R. P. Ross,et al. The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission , 2009, The American Journal of Gastroenterology.
[7] C. Kelly. A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection. , 2009, JAMA.
[8] K. Garey,et al. WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas. , 2009, Anaerobe.
[9] P. Rutgeerts,et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.
[10] K. Garey,et al. Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study , 2009, Journal of clinical gastroenterology.
[11] E. Dubberke,et al. Review of Current Literature on the Economic Burden of Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.
[12] L. Mcfarland. Renewed interest in a difficult disease: Clostridium difficile infections – epidemiology and current treatment strategies , 2009, Current opinion in gastroenterology.
[13] K. Garey,et al. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. , 2008, The Journal of hospital infection.
[14] E. Giovannucci,et al. Long-term outcomes of laparoscopic versus open ileocolic resection for Crohn's disease: follow-up of a prospective randomized trial , 2008, JAMA.
[15] H. Dupont,et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] K. Aktories,et al. Processing of Clostridium difficile toxins. , 2008, Journal of medical microbiology.
[17] G. Kaplan,et al. A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.
[18] R. Nelson,et al. Probiotics for treatment of Clostridium difficile-associated colitis in adults. , 2008, The Cochrane database of systematic reviews.
[19] J. Bartlett,et al. Clinical recognition and diagnosis of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] Carlene A. Muto,et al. Treatment of Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] Carlene A. Muto,et al. Measures to control and prevent Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] Oldfield Ec rd. Use of a rifaximin "chaser" in the treatment of recurrent Clostridium difficile-associated diarrhea. , 2008 .
[23] K. Aktories,et al. Clostridium difficile Glucosyltransferase Toxin B-essential Amino Acids for Substrate Binding* , 2007, Journal of Biological Chemistry.
[24] A. Ananthakrishnan,et al. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.
[25] Melinda B Davis,et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] D. Musher,et al. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. , 2007, The Journal of antimicrobial chemotherapy.
[27] D. Gerding,et al. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] Kimberly A. Reske,et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] S. Fanning,et al. Isolation and Characterization of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland , 2017 .
[30] Dawn B. Beaulieu,et al. Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[31] J. Weese,et al. Clostridium difficile in Retail Ground Meat, Canada , 2007, Emerging infectious diseases.
[32] C. Brensinger,et al. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis. , 2007, Gastroenterology.
[33] D. Binion,et al. Clostridium difficile Enteritis: An Early Postoperative Complication in Inflammatory Bowel Disease Patients After Colectomy , 2007, Journal of Gastrointestinal Surgery.
[34] D. Juurlink,et al. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Goldblum,et al. Clostridium Difficile-Associated Pouchitis , 2006, Digestive Diseases and Sciences.
[36] S. Suissa,et al. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy , 2006, Canadian Medical Association Journal.
[37] Dawn B. Beaulieu,et al. Rifaximin and Treatment of Recurrent Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: 1206 , 2006 .
[38] D. Musher,et al. Nitazoxanide for the treatment of Clostridium difficile colitis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] J. Bartlett. New drugs for Clostridium difficile infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] D. Rampton,et al. “Diversion” Colitis Caused by Clostridium difficile Infection: Report of a Case , 2006, Diseases of the colon and rectum.
[41] D. Gerding,et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. , 2006, The Journal of infectious diseases.
[42] D. Musher. Pneumococcal vaccine--direct and indirect ("herd") effects. , 2006, The New England journal of medicine.
[43] L. Mcfarland. Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.
[44] K. Iwata,et al. Epidemic Clostridium difficile. , 2006, The New England journal of medicine.
[45] C. Rees,et al. Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea , 2006, Diseases of the colon and rectum.
[46] S. Routhier,et al. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] M. Owings,et al. Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging Infectious Diseases.
[48] K. Carroll,et al. Effective Detection of Toxigenic Clostridium difficile by a Two-Step Algorithm Including Tests for Antigen and Cytotoxin , 2006, Journal of Clinical Microbiology.
[49] T. Åkerlund,et al. Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile-Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates , 2006, Journal of Clinical Microbiology.
[50] S. Clark,et al. The outcome of surgery in fulminant Clostridium difficile colitis , 2006, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[51] C. Cunningham-Rundles,et al. Inflammatory and autoimmune complications of common variable immune deficiency. , 2006, Autoimmunity reviews.
[52] J. Songer,et al. Clostridium difficile: an important pathogen of food animals. , 2006, Anaerobe.
[53] E. Kuijper,et al. Emergence of Clostridium difficile-associated disease in North America and Europe. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[54] F. Hayetian,et al. Ileal perforation secondary to Clostridium difficile enteritis: report of 2 cases. , 2006, Archives of surgery.
[55] A. Barkun,et al. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.
[56] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[57] Ken Dewar,et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.
[58] L. Lanthier,et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] L. Valiquette,et al. Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.
[60] Jon Brazier,et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.
[61] D. Musher,et al. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. , 2005, The Lancet. Infectious diseases.
[62] J. Starr. Clostridium difficile associated diarrhoea: diagnosis and treatment , 2005, BMJ : British Medical Journal.
[63] D. Musher,et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] K. Carroll,et al. Frequency of Sample Submission for Optimal Utilization of the Cell Culture Cytotoxicity Assay for Detection of Clostridium difficile Toxin , 2005, Journal of Clinical Microbiology.
[65] J. Pépin,et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] J. Ballard,et al. Clostridium difficile Toxins: Mechanism of Action and Role in Disease , 2005, Clinical Microbiology Reviews.
[67] Carlene A. Muto,et al. A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use , 2005, Infection Control & Hospital Epidemiology.
[68] M. Parmar. Treating C. difficile , 2005, Canadian Medical Association Journal.
[69] C. Branger,et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. , 2005, Journal of medical microbiology.
[70] L. Mcfarland. Alternative treatments for Clostridium difficile disease: what really works? , 2005, Journal of medical microbiology.
[71] D. Gerding,et al. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[72] P. A. Kantrowitz,et al. Clostridium difficile enteritis , 1993, Digestive Diseases and Sciences.
[73] J. Leighton,et al. The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease , 2004, Journal of clinical gastroenterology.
[74] Louis Valiquette,et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.
[75] D. Rampton,et al. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.
[76] A. Huang,et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies , 2004, Canadian Medical Association Journal.
[77] S. Poutanen,et al. Clostridium difficile-associated diarrhea in adults , 2004, Canadian Medical Association Journal.
[78] I. Odenholt,et al. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.
[79] M. Wilcox. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.
[80] R. Gaynes,et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] P. Giannasca,et al. Active and passive immunization against Clostridium difficile diarrhea and colitis. , 2004, Vaccine.
[82] E. Elinav,et al. Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis , 2004, International Journal of Colorectal Disease.
[83] M. Rupnik,et al. Binary toxin producing Clostridium difficile strains. , 2003, Anaerobe.
[84] J. Starr,et al. Clostridium difficile in a geriatric unit: a prospective epidemiological study employing a novel S-layer typing method. , 2003, Journal of medical microbiology.
[85] M. Wilcox,et al. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. , 2003, The Journal of hospital infection.
[86] J. Bakken,et al. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[87] A. Thillainayagam,et al. Clostridium Difficile Infection—An Unusual Cause of Refractory Pouchitis: Report of a Case , 2003, Diseases of the colon and rectum.
[88] C. Kelly,et al. Underlying Disease Severity as a Major Risk Factor for Nosocomial Clostridium difficile Diarrhea , 2002, Infection Control & Hospital Epidemiology.
[89] I. Fong,et al. Fulminant clostridium difficile colitis without diarrhea: lack of emphasis in diagnostic guidelines , 2002, American Journal of Gastroenterology.
[90] Lynne V McFarland,et al. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.
[91] C. Sirio,et al. Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications , 2002, Annals of surgery.
[92] C. Kelly,et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] J. Bartlett,et al. Clinical practice. Antibiotic-associated diarrhea. , 2002, New England Journal of Medicine.
[94] S. Durning,et al. Clostridium difficile small bowel enteritis occurring after total colectomy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[95] L. Peterson,et al. Fatal Pseudomembranous Colitis Associated with a Variant Clostridium difficile Strain Not Detected by Toxin A Immunoassay , 2001, Annals of Internal Medicine.
[96] J. Tjandra,et al. Fatal Clostridium difficile infection of the small bowel after complex colorectal surgery , 2001, ANZ journal of surgery.
[97] J. Gradon,et al. Extracolonic Manifestations of Clostridium difficile Infections: Presentation of 2 Cases and Review of the Literature , 2001, Medicine.
[98] E. Mylonakis,et al. Clostridium difficile--Associated diarrhea: A review. , 2001, Archives of internal medicine.
[99] L B Reller,et al. Practice guidelines for the management of infectious diarrhea. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[100] C. Kelly,et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea , 2001, The Lancet.
[101] M. Wilcox,et al. Hospital disinfectants and spore formation by Clostridium difficile , 2000, The Lancet.
[102] T. Leet,et al. Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[103] M. Schein,et al. Acute Abdomen and Clostridium difficile Colitis: Still a Lethal Combination , 2000, Digestive Surgery.
[104] Z. Vesoulis,et al. Pseudomembranous enteritis after proctocolectomy , 2000, Diseases of the colon and rectum.
[105] C. Kelly,et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. , 2000, The New England journal of medicine.
[106] H. Solomon,et al. Clostridium difficile colitis requiring subtotal colectomy in a renal transplant recipient: a case report and review of literature. , 1998, Transplantation proceedings.
[107] D. Yadav,et al. Clostridium difficile colitis: factors influencing treatment failure and relapse—a prospective evaluation , 1998, American Journal of Gastroenterology.
[108] G E Bignardi,et al. Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.
[109] M. Alfa,et al. Survey of Incidence of Clostridium difficile Infection in Canadian Hospitals and Diagnostic Approaches , 1998, Journal of Clinical Microbiology.
[110] S. Borriello,et al. Pathogenesis of Clostridium difficile infection. , 1998, The Journal of antimicrobial chemotherapy.
[111] C. Griffiths,et al. The role of surgery in pseudomembranous enterocolitis. , 1998, Postgraduate medical journal.
[112] K. Mealy,et al. Timing of surgery for fulminating pseudomembranous colitis , 1998, The British journal of surgery.
[113] R. Fekety. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee. , 1997, The American journal of gastroenterology.
[114] R. Karmy-Jones,et al. Pseudomembranous colitis with associated fulminant ileitis in the defunctionalized limb of a jejunal-ileal bypass , 1997, Diseases of the colon and rectum.
[115] M. Weidmann,et al. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. , 1997, European journal of biochemistry.
[116] S. Grundfest-Broniatowski,et al. Clostridium difficile colitis in the critically Ill , 1996, Diseases of the colon and rectum.
[117] W. Graninger,et al. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[118] M. Samore,et al. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. , 1996, The American journal of medicine.
[119] H. Yee,et al. Fatal Clostridium difficile enteritis after total abdominal colectomy. , 1996, Journal of clinical gastroenterology.
[120] Richard D Moore,et al. Clostridium difficile Colitis: An Efficient Clinical Approach to Diagnosis , 1995, Annals of Internal Medicine.
[121] A. Barkun,et al. Toxic megacolon complicating pseudomembranous enterocolitis , 1995, Diseases of the colon and rectum.
[122] M. Wilcox,et al. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. , 1995, The Journal of antimicrobial chemotherapy.
[123] L. Peterson,et al. Clostridium Difficile-Associated Diarrhea and Colitis , 1995, Infection Control & Hospital Epidemiology.
[124] M. Mulligan,et al. Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[125] Elaine Larson,et al. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1995, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[126] L. Morris,et al. Management of pseudomembranous colitis. , 1994, The American surgeon.
[127] G. Bongaerts,et al. Role of toxins A and B in the pathogenesis of Clostridium difficile disease. , 1994, Microbial pathogenesis.
[128] D. Gerding,et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. , 1994 .
[129] M. Holodniy,et al. Antibiotic-associated pseudomembranous enteritis due to Clostridium difficile. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[130] K. Lillemoe,et al. Pseudomembranous colitis: a surgical disease? , 1994, Surgery.
[131] A. Shah,et al. Diagnosis and treatment of Clostridium difficile colitis. , 1993, JAMA.
[132] Fausto,et al. Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea , 1992, Antimicrobial Agents and Chemotherapy.
[133] L. Peterson,et al. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. , 1992, The Journal of infectious diseases.
[134] R. Simmons,et al. Laparotomy for fulminant pseudomembranous colitis. , 1992, Archives of surgery.
[135] M. Scheurlen,et al. Microbic Superinfection in Relapse of Inflammatory Bowel Disease , 1992, Journal of clinical gastroenterology.
[136] J. Gryboski. Clostridium difficile in Inflammatory Bowel Disease Relapse , 1991, Journal of pediatric gastroenterology and nutrition.
[137] D. Miller,et al. Perforation complicating rifampin-associated pseudomembranous enteritis. , 1989, Archives of surgery.
[138] B. Guglielmo,et al. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. , 1989, The Journal of infectious diseases.
[139] J. Rask-Madsen,et al. BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.
[140] W. Stamm,et al. Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.
[141] M. Tvede,et al. Bacteriotherapy for chronic relapsing Clostridium difficile in six patients , 1989 .
[142] J. Silva,et al. Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens. , 1989, The American journal of medicine.
[143] M. Wilson,et al. Absence of diarrhea in toxic megacolon complicating Clostridium difficile pseudomembranous colitis. , 1988, The American journal of gastroenterology.
[144] D. Kleinfeld,et al. Parenteral therapy for antibiotic-associated pseudomembranous colitis. , 1988, The Journal of infectious diseases.
[145] P. Bingley,et al. Clostridium difficile colitis following treatment with metronidazole and vancomycin. , 1987, Postgraduate medical journal.
[146] R. Bolton,et al. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. , 1986, Gut.
[147] M. Dudley,et al. Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial. , 1986, Archives of internal medicine.
[148] D. Gordon,et al. Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. , 1985, Gastroenterology.
[149] D. Gordon,et al. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. , 1985, The American journal of gastroenterology.
[150] M. Gerson,et al. Salmonella infections complicating inflammatory bowel disease. , 1985, Journal of clinical gastroenterology.
[151] K. Saum,et al. Effects of Clostridium difficile toxins given intragastrically to animals , 1985, Infection and immunity.
[152] B. Aronsson,et al. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. , 1984, Scandinavian journal of infectious diseases.
[153] D. Gerding,et al. PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.
[154] J. Shortland,et al. Pseudomembranous colitis associated with changes in an ileal conduit. , 1983, Journal of clinical pathology.
[155] D. Rampton,et al. Nonspecific ulcerative colitis as a sequel to amebic dysentery. , 1983, Journal of clinical gastroenterology.
[156] R. Möllby,et al. Occurrence of Clostridium difficile toxin in inflammatory bowel disease. , 1983, Scandinavian journal of gastroenterology.
[157] K. Das,et al. Salmonellosis complicating ulcerative colitis. Treatment with trimethoprim-sulfamethoxazole. , 1982, JAMA.
[158] Tedesco Fj. Treatment of recurrent antibiotic-associated pseudomembranous colitis. , 1982 .
[159] J. Bartlett,et al. Comparison of two toxins produced by Clostridium difficile , 1981, Infection and immunity.
[160] B. Greene,et al. 12 MONTH FOLLOW-UP OF MEBENDAZOLE THERAPY FOR ONCHOCERCIASIS , 1981, The Lancet.
[161] M. Ar,et al. Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. , 1981 .
[162] Y. Trnka,et al. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. , 1981, Gastroenterology.
[163] A. Read,et al. CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHŒA: A ROLE IN INFLAMMATORY BOWEL DISEASE? , 1980, The Lancet.
[164] Y. Trnka,et al. THERAPEUTIC IMPLICATIONS OF CLOSTRIDIUM DIFFICILE TOXIN DURING RELAPSE OF CHRONIC INFLAMMATORY BOWEL DISEASE , 1980, The Lancet.
[165] M. Keighley,et al. Therapeutic trials of antibiotic associated colitis. , 1980, Scandinavian journal of infectious diseases. Supplementum.
[166] M. Keighley,et al. Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. , 1978, British medical journal.
[167] J. Bartlett,et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. , 1978, The New England journal of medicine.
[168] J. Bartlett,et al. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. , 1977, The Journal of infectious diseases.
[169] R. Barton,et al. Clindamycin-associated colitis. A prospective study. , 1974, Annals of internal medicine.
[170] J. Crooks,et al. THE FAMILY DOCTOR IN THE CONTEXT OF BRITAIN'S SOCIAL SERVICES. , 1965, Lancet.
[171] I. C. Hall,et al. INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .